Skip to content

Clinical trials

Phase 3 Hepatitis C, Chronic trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Phase: Phase 3 Country / region: Germany Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20073
20082
20091
20101
20115
20127
20132
20141
20161
20173
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Boehringer Ingelheim4
Gilead Sciences3
Janssen-Cilag International NV3
Debiopharm International SA2
GlaxoSmithKline2
Hoffmann-La Roche2
Human Genome Sciences Inc.2
Atea Pharmaceuticals, Inc.1
Janssen Infectious Diseases BVBA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic30
Hepatitis C14
Hepatitis4
Fibrosis2
Infections2
Acquired Immunodeficiency Syndrome1
Digestive System Diseases1
Enterovirus Infections1
Flaviviridae Infections1
Hepatitis, Chronic1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.